☰

Takahiro Ito - Publications

Affiliations: 
University of Georgia, Athens, Athens, GA, United States 
Tree Info Grants Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Jimbo K, Hattori A, Koide S, Ito T, Sasaki K, Iwai K, Nannya Y, Iwama A, Tojo A, Konuma T. Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia. Leukemia. PMID 36352193 DOI: 10.1038/s41375-022-01750-7  0.391
2022 Jimbo K, Nakajima-Takagi Y, Ito T, Koide S, Nannya Y, Iwama A, Tojo A, Konuma T. Immunoglobulin superfamily member 8 maintains myeloid leukemia stem cells through inhibition of β-catenin degradation. Leukemia. PMID 35418614 DOI: 10.1038/s41375-022-01564-7  0.441
2020 Spinler K, Bajaj J, Ito T, Zimdahl B, Hamilton M, Ahmadi A, Koechlein CS, Lytle N, Kwon HY, Anower-E-Khuda F, Sun H, Blevins A, Weeks J, Kritzik M, Karlseder J, et al. A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia. Nature Communications. 11: 5998. PMID 33243988 DOI: 10.1038/s41467-020-19782-x  0.787
2020 Ito T. Reprogramming cell fates by RNA binding proteins in stem cells and cancer The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.00216  0.463
2018 Spinler K, Reya T, Bajaj J, Ito T, Zimdahl B, Ahmadi A, Koechlein C, Lytle N, Kwon HY, Anower-E-Khuda F, Kritzik M, Karlseder J, Park PW, Esko J. Identification of Syndecan-1 As a Key Dependency of Myeloid Leukemia Growth and Dissemination Blood. 132: 3003-3003. DOI: 10.1182/Blood-2018-99-115199  0.753
2017 Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, Tayyari F, McSkimming D, Kannan N, Tojo A, Edison AS, Ito T. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. PMID 28514443 DOI: 10.1038/Nature22314  0.448
2017 Hattori A, McSkimming D, Kannan N, Ito T. RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia. Leukemia Research. 54: 47-54. PMID 28107692 DOI: 10.1016/J.Leukres.2017.01.015  0.461
2017 Ito T, Hattori A. Disease progression by reprogrammed bcaa metabolism in myeloid leukemia Experimental Hematology. 53. DOI: 10.1016/J.Exphem.2017.06.351  0.322
2016 Koechlein CS, Harris JR, Lee TK, Weeks J, Fox RG, Zimdahl B, Ito T, Blevins A, Jung SH, Chute JP, Chourasia A, Covert MW, Reya T. High-resolution imaging and computational analysis of haematopoietic cell dynamics in vivo. Nature Communications. 7: 12169. PMID 27425143 DOI: 10.1038/Ncomms12169  0.778
2016 Fox RG, Lytle NK, Jaquish DV, Park FD, Ito T, Bajaj J, Koechlein CS, Zimdahl B, Yano M, Kopp JL, Kritzik M, Sicklick JK, Sander M, Grandgenett PM, Hollingsworth MA, et al. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature. PMID 27281208 DOI: 10.1038/Nature17988  0.749
2016 Hattori A, Buac K, Ito T. Regulation of Stem Cell Self-Renewal and Oncogenesis by RNA-Binding Proteins. Advances in Experimental Medicine and Biology. 907: 153-88. PMID 27256386 DOI: 10.1007/978-3-319-29073-7_7  0.482
2015 Kwon HY, Bajaj J, Ito T, Blevins A, Konuma T, Weeks J, Lytle NK, Koechlein CS, Rizzieri D, Chuah C, Oehler VG, Sasik R, Hardiman G, Reya T. Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia. Cell Stem Cell. 17: 152-64. PMID 26212080 DOI: 10.1016/J.Stem.2015.06.006  0.803
2015 Kwon HY, Bajaj J, Ito T, Blevins A, Konuma T, Weeks J, Lytle NK, Koechlein CS, Rizzieri D, Chuah C, Oehler VG, Sasik R, Hardiman G, Reya T. Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia Cell Stem Cell. 17: 152-164. DOI: 10.1016/j.stem.2015.06.006  0.593
2014 Lento W, Ito T, Zhao C, Harris JR, Huang W, Jiang C, Owzar K, Piryani S, Racioppi L, Chao N, Reya T. Loss of β-catenin triggers oxidative stress and impairs hematopoietic regeneration. Genes & Development. 28: 995-1004. PMID 24788518 DOI: 10.1101/Gad.231944.113  0.774
2014 Zimdahl B, Ito T, Blevins A, Bajaj J, Konuma T, Weeks J, Koechlein CS, Kwon HY, Arami O, Rizzieri D, Broome HE, Chuah C, Oehler VG, Sasik R, Hardiman G, et al. Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia. Nature Genetics. 46: 245-52. PMID 24487275 DOI: 10.1038/Ng.2889  0.77
2013 Ito T. Stem cell maintenance and disease progression in chronic myeloid leukemia. International Journal of Hematology. 98: 641-7. PMID 23550022 DOI: 10.1007/S12185-013-1318-8  0.507
2013 Kurokawa M, Ito T, Yang CS, Zhao C, Macintyre AN, Rizzieri DA, Rathmell JC, Deininger MW, Reya T, Kornbluth S. Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells. Proceedings of the National Academy of Sciences of the United States of America. 110: 2300-5. PMID 23324740 DOI: 10.1073/Pnas.1206551110  0.667
2012 Himburg HA, Harris JR, Ito T, Daher P, Russell JL, Quarmyne M, Doan PL, Helms K, Nakamura M, Fixsen E, Herradon G, Reya T, Chao NJ, Harroch S, Chute JP. Pleiotrophin regulates the retention and self-renewal of hematopoietic stem cells in the bone marrow vascular niche. Cell Reports. 2: 964-75. PMID 23084748 DOI: 10.1016/J.Celrep.2012.09.002  0.706
2012 Fereshteh M, Ito T, Kovacs JJ, Zhao C, Kwon HY, Tornini V, Konuma T, Chen M, Lefkowitz RJ, Reya T. β-Arrestin2 mediates the initiation and progression of myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 109: 12532-7. PMID 22773819 DOI: 10.1073/Pnas.1209815109  0.738
2012 Ito T, Zimdahl B, Reya T. aSIRTing control over cancer stem cells. Cancer Cell. 21: 140-2. PMID 22340585 DOI: 10.1016/J.Ccr.2012.01.014  0.791
2012 Himburg H, Ito T, Harris J, Quarmyne M, Helms K, Doan P, Reya T, Chao N, Chute J. Pleiotrophin Regulates Normal and Leukemic Hematopoietic Stem Cell Fate Biology of Blood and Marrow Transplantation. 18: S236. DOI: 10.1016/J.Bbmt.2011.12.498  0.725
2010 Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L, Goldman J, Goh H, Kim SH, Kim DW, Chuah C, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 466: 765-8. PMID 20639863 DOI: 10.1038/Nature09171  0.729
2010 Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L, Goldman J, Goh H, Kim S, Kim D, Chuah C, et al. P73. Regulation of myeloid leukemia by the cell fate determinant Musashi Differentiation. 80: S41. DOI: 10.1016/J.Diff.2010.09.079  0.777
2009 Fosbrink M, Cudrici C, Tegla CA, Soloviova K, Ito T, Vlaicu S, Rus V, Niculescu F, Rus H. Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Experimental and Molecular Pathology. 86: 87-94. PMID 19162005 DOI: 10.1016/j.yexmp.2008.12.005  0.308
2008 Vlaicu SI, Cudrici C, Ito T, Fosbrink M, Tegla CA, Rus V, Mircea PA, Rus H. Role of response gene to complement 32 in diseases. Archivum Immunologiae Et Therapiae Experimentalis. 56: 115-22. PMID 18373239 DOI: 10.1007/s00005-008-0016-3  0.362
2007 Ito T, Saso K, Arimitsu N, Sekimizu K. Defective FESTA/EAF2-mediated transcriptional activation in S-II-deficient embryonic stem cells. Biochemical and Biophysical Research Communications. 363: 603-9. PMID 17892859 DOI: 10.1016/J.Bbrc.2007.09.009  0.365
2007 Nagata M, Arimitsu N, Ito T, Sekimizu K. Antioxidant N-acetyl-L-cysteine inhibits erythropoietin-induced differentiation of erythroid progenitors derived from mouse fetal liver. Cell Biology International. 31: 252-6. PMID 17174578 DOI: 10.1016/J.Cellbi.2006.11.001  0.375
2006 Ito T, Arimitsu N, Takeuchi M, Kawamura N, Nagata M, Saso K, Akimitsu N, Hamamoto H, Natori S, Miyajima A, Sekimizu K. Transcription elongation factor S-II is required for definitive hematopoiesis. Molecular and Cellular Biology. 26: 3194-203. PMID 16581793 DOI: 10.1128/Mcb.26.8.3194-3203.2006  0.378
Show low-probability matches.